Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Current Leases (2019 - 2025)

Historic Current Leases for Abeona Therapeutics (ABEO) over the last 7 years, with Q3 2025 value amounting to $102000.0.

  • Abeona Therapeutics' Current Leases fell 9035.0% to $102000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $102000.0, marking a year-over-year decrease of 9035.0%. This contributed to the annual value of $823000.0 for FY2024, which is 1753.51% down from last year.
  • Per Abeona Therapeutics' latest filing, its Current Leases stood at $102000.0 for Q3 2025, which was down 9035.0% from $537000.0 recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Current Leases high stood at $1.8 million for Q1 2022, and its period low was $102000.0 during Q3 2025.
  • Its 5-year average for Current Leases is $1.4 million, with a median of $1.7 million in 2021.
  • Per our database at Business Quant, Abeona Therapeutics' Current Leases surged by 1221.04% in 2024 and then crashed by 9035.0% in 2025.
  • Abeona Therapeutics' Current Leases (Quarter) stood at $1.8 million in 2021, then dropped by 2.48% to $1.8 million in 2022, then crashed by 43.71% to $998000.0 in 2023, then decreased by 17.54% to $823000.0 in 2024, then tumbled by 87.61% to $102000.0 in 2025.
  • Its Current Leases stands at $102000.0 for Q3 2025, versus $537000.0 for Q2 2025 and $613000.0 for Q1 2025.